Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:10908724rdf:typepubmed:Citationlld:pubmed
pubmed-article:10908724lifeskim:mentionsumls-concept:C1646870lld:lifeskim
pubmed-article:10908724lifeskim:mentionsumls-concept:C0333348lld:lifeskim
pubmed-article:10908724lifeskim:mentionsumls-concept:C0086982lld:lifeskim
pubmed-article:10908724lifeskim:mentionsumls-concept:C1705920lld:lifeskim
pubmed-article:10908724lifeskim:mentionsumls-concept:C1999216lld:lifeskim
pubmed-article:10908724lifeskim:mentionsumls-concept:C0916529lld:lifeskim
pubmed-article:10908724pubmed:issue3lld:pubmed
pubmed-article:10908724pubmed:dateCreated2000-8-18lld:pubmed
pubmed-article:10908724pubmed:abstractTextIn a search for new inhibitors of the IFN-gamma mediated signal transduction in HeLa S3 cells using secreted alkaline phosphatase (SEAP) as reporter gene, the novel pyran-dione trichodion was isolated from fermentations of the imperfect fungus Trichosporiella sp. 20-95. The compound inhibits the IFN-gamma mediated expression of the reporter gene with IC(50) values of 21-42 microM (5-10 microgram/ml). The NF-kappaB and AP-1 mediated expression of the reporter gene are inhibited with IC(50) values of 42-84 microM (10-20 microgram/ml) and 21 microM (5 microgram/ml) respectively. Western blotting with COX-2 and NOS II antibodies showed that the expression of both proinflammatory enzymes is almost completely inhibited at 21-42 microM (5-10 microgram/ml) in LPS/IFN-gamma stimulated J774 mouse macrophages. Studies on the mode of action of the compound revealed that the inhibition of the NF-kappaB dependent pathway is due to the stabilization of the IkappaB protein and the inhibition of the IFN-gamma dependent signaling is caused by an inhibition of the phosphorylation of the STAT1alpha transcription factor.lld:pubmed
pubmed-article:10908724pubmed:languageenglld:pubmed
pubmed-article:10908724pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10908724pubmed:citationSubsetIMlld:pubmed
pubmed-article:10908724pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10908724pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10908724pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10908724pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10908724pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10908724pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10908724pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10908724pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10908724pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10908724pubmed:statusMEDLINElld:pubmed
pubmed-article:10908724pubmed:monthJullld:pubmed
pubmed-article:10908724pubmed:issn0014-5793lld:pubmed
pubmed-article:10908724pubmed:authorpubmed-author:ErkenEElld:pubmed
pubmed-article:10908724pubmed:issnTypePrintlld:pubmed
pubmed-article:10908724pubmed:day21lld:pubmed
pubmed-article:10908724pubmed:volume477lld:pubmed
pubmed-article:10908724pubmed:ownerNLMlld:pubmed
pubmed-article:10908724pubmed:authorsCompleteYlld:pubmed
pubmed-article:10908724pubmed:pagination219-23lld:pubmed
pubmed-article:10908724pubmed:dateRevised2009-11-19lld:pubmed
pubmed-article:10908724pubmed:meshHeadingpubmed-meshheading:10908724...lld:pubmed
pubmed-article:10908724pubmed:meshHeadingpubmed-meshheading:10908724...lld:pubmed
pubmed-article:10908724pubmed:meshHeadingpubmed-meshheading:10908724...lld:pubmed
pubmed-article:10908724pubmed:meshHeadingpubmed-meshheading:10908724...lld:pubmed
pubmed-article:10908724pubmed:meshHeadingpubmed-meshheading:10908724...lld:pubmed
pubmed-article:10908724pubmed:meshHeadingpubmed-meshheading:10908724...lld:pubmed
pubmed-article:10908724pubmed:meshHeadingpubmed-meshheading:10908724...lld:pubmed
pubmed-article:10908724pubmed:meshHeadingpubmed-meshheading:10908724...lld:pubmed
pubmed-article:10908724pubmed:meshHeadingpubmed-meshheading:10908724...lld:pubmed
pubmed-article:10908724pubmed:meshHeadingpubmed-meshheading:10908724...lld:pubmed
pubmed-article:10908724pubmed:meshHeadingpubmed-meshheading:10908724...lld:pubmed
pubmed-article:10908724pubmed:meshHeadingpubmed-meshheading:10908724...lld:pubmed
pubmed-article:10908724pubmed:meshHeadingpubmed-meshheading:10908724...lld:pubmed
pubmed-article:10908724pubmed:meshHeadingpubmed-meshheading:10908724...lld:pubmed
pubmed-article:10908724pubmed:meshHeadingpubmed-meshheading:10908724...lld:pubmed
pubmed-article:10908724pubmed:meshHeadingpubmed-meshheading:10908724...lld:pubmed
pubmed-article:10908724pubmed:meshHeadingpubmed-meshheading:10908724...lld:pubmed
pubmed-article:10908724pubmed:year2000lld:pubmed
pubmed-article:10908724pubmed:articleTitleTrichodion, a new inhibitor of inflammatory signal transduction pathways from a Trichosporiella species.lld:pubmed
pubmed-article:10908724pubmed:affiliationInstitut für Biotechnologie und Wirkstoff-Forschung e.V., Erwin-Schrödinger-Str. 56, D-67663, Kaiserslautern, Germany. erkel@ibwf.uni-kl.delld:pubmed
pubmed-article:10908724pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:10908724pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed